Novo Nordisk

NOVO B DKK0.1 B
Create an alert
Sell299.25 DKK
Buy299.40 DKK
4.70 DKK (1.59%)
Last updated today at
Back to dashboard

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
10 February 2026
Karsten Munk KnudsenCFO
Sell
Option/Award related
26,246315.60 DKK8,283,237.60 DKK147,417
10 February 2026
Karsten Munk KnudsenCFO
Sell
Option/Award related
311315.70 DKK98,182.70 DKK147,106
9 February 2026
Martin Holst LangeChief Level Officer
Sell
Tax related
22,000319.80 DKK7,035,600.00 DKK47,403
4 February 2026
David Scott (Dave) MooreExecutive Vice President
Sell
Tax related
6,845304.72 DKK2,085,808.40 DKK0
4 February 2026
Emil Kongshoj LarsenExecutive Vice President
Sell
Tax related
3,645304.72 DKK1,110,704.40 DKK0
17 November 2025
Stephan EngelsIndependent Director
Buy
Regular purchase transaction
6,450312.50 DKK2,015,625.00 DKK6,450
10 November 2025
David Scott (Dave) MooreExecutive Vice President
Sell
Tax related
8,160297.95 DKK2,431,301.74 DKK0

End of results. Director deals are only available for the last 12 months.

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
10 February 2026
Karsten Munk KnudsenCFO
Sell
Option/Award related
26,246315.60 DKK8,283,237.60 DKK147,417
9 February 2026
Martin Holst LangeChief Level Officer
Sell
Tax related
22,000319.80 DKK7,035,600.00 DKK47,403
10 November 2025
David Scott (Dave) MooreExecutive Vice President
Sell
Tax related
8,160297.95 DKK2,431,301.74 DKK0
4 February 2026
David Scott (Dave) MooreExecutive Vice President
Sell
Tax related
6,845304.72 DKK2,085,808.40 DKK0
17 November 2025
Stephan EngelsIndependent Director
Buy
Regular purchase transaction
6,450312.50 DKK2,015,625.00 DKK6,450

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.